Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system
Digital Health Global
MARCH 28, 2024
Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). Daewoong aims to leverage AI technology to reduce the drug development period to seven years and costs to approximately 600 billion won ($450 million).
Let's personalize your content